Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Macrophages
100%
FDA-approved Drugs
100%
Mycobacterium
100%
Inducing Autophagy
100%
Amoxapine
100%
Intracellular Killing
66%
Autophagy
50%
Mycobacterium Tuberculosis (M. tb)
50%
Host Cell
16%
Intracellular Pathogen
16%
Resistant Strains
16%
Human Macrophages
16%
Cell-based
16%
Knockdown
16%
Host Defense
16%
Novel Therapeutics
16%
Mammalian Target of Rapamycin (mTOR)
16%
Beneficial Effects
16%
Cytotoxicity
16%
Host Defense Mechanisms
16%
Post-infection
16%
Chemical Inhibitors
16%
Public Health Emergency
16%
Treatment Regimen
16%
Antibiotic Resistance
16%
Antidepressants
16%
Murine Macrophages
16%
Mycobacterium Bovis BCG
16%
Novel Host
16%
Killing Effect
16%
3-methyladenine (3-MA)
16%
Reduced Cytotoxicity
16%
Autophagic Pathway
16%
Global Public Health
16%
Mycobacterial Infection
16%
Host-directed
16%
Macrophage Cytotoxicity
16%
Autophagic Flux
16%
Anti-tubercular Treatment
16%
ATG16L1
16%
Immunology and Microbiology
Macrophage
100%
Autophagy
100%
Mycobacteria
100%
Intracellular Killing
66%
Cytotoxicity
50%
Host Resistance
33%
Host Cell
16%
Infectious Agent
16%
Mycobacterium Tuberculosis
16%
Mycobacterium Bovis BCG
16%
Murine
16%
Sirolimus
16%
ATG16L1
16%
Infection
16%
Antibiotic Resistance
16%